Scilex Holding Co (SCLX)
0.6781
-0.06
(-8.36%)
USD |
NASDAQ |
Nov 14, 16:00
0.67
-0.01
(-1.19%)
After-Hours: 20:00
Scilex Gross Profit Margin (Quarterly): 73.18% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.18% |
| March 31, 2024 | 64.72% |
| December 31, 2023 | 66.42% |
| September 30, 2023 | 66.47% |
| June 30, 2023 | 66.80% |
| Date | Value |
|---|---|
| March 31, 2023 | 66.06% |
| December 31, 2022 | 62.14% |
| September 30, 2022 | 68.26% |
| June 30, 2022 | 80.71% |
| March 31, 2022 | 83.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.14%
Minimum
Dec 2022
83.21%
Maximum
Mar 2022
69.80%
Average
66.64%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.83% |
| Masimo Corp | 52.16% |
| Oramed Pharmaceuticals Inc | -- |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 76.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -117.9% |
| Profit Margin (Quarterly) | -229.6% |
| Operating Margin (Quarterly) | -95.44% |
| Return on Net Operating Assets | -137.5% |